Lina Benajiba

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

21h-index3.8kcitations179works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(36), RNA Interference and Gene Delivery(35), Myeloproliferative Neoplasms: Diagnosis and Treatment(33), Folate and B Vitamins Research(32), Monoclonal and Polyclonal Antibodies Research(23)

Publications179 total

Retromomelo: Real-world use of momelotinib – the french experience from the FIM group
Blood·2025
Outcome of patients with accelerated and blast‐phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination—A FIM study
HemaSphere·2025· 1 citedOpen Access
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Nature Communications·2025· 3 citedOpen Access
A molecular signature predicts hematologic evolution in polycythemia vera patients
Leukemia·2025Open Access
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cells
EMBO Reports·2025· 1 citedOpen Access
Actualités clinicobiologiques dans les néoplasies myéloprolifératives
Hématologie·2025
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis
Blood Advances·2024· 8 citedOpen Access
Outcome of Patients with Accelerated and Blast-Phase Myeloproliferative Neoplasms Ineligible for Intensive Chemotherapy or Allogeneic Hematopoietic Cell Transplantation Treated By Azacitidine Alone or in Combination - a FIM Study
Blood·2024· 1 cited
Odyssey: A First-in-Human Study of the Aldehyde Dehydrogenase (ALDH) Inhibitor Abd-3001 in Patients with Refractory/Relapsed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Blood·2024· 1 cited
JAK Inhibition Results in Aggressive Cutaneous Squamous Cell Carcinoma through MAPK Pathway Activation and Shapes the Tumor Immune Microenvironment to Create Novel Therapeutic Opportunities
Blood·2024
<i>SH2B3 L</i>oss of Function Variants Are Potential Drivers of Severe Thrombocytosis
Blood·2024· 1 cited
Current myeloproliferative neoplasm scoring systems for clinical practice
Blood·2024· 8 cited
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis—insights from a multicenter study
Leukemia·2024· 2 cited
Supplementary Figure S1 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024Open Access
Supplementary Table 2 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024Open Access
Supplementary Table 3 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024Open Access
Supplementary Figure S4 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024Open Access
Supplementary Figure S6 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024Open Access
Supplementary Figure S2 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024Open Access
Supplementary Figure S3 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024Open Access
page 1 of 9Next →

Frequent Co-authors

Jean‐Jacques Kiladjian(20), Rafael Daltro De Oliveira(15), Bruno Cassinat(14), Emmanuel Raffoux(13), Alexandre Puissant(12), Nabih Maslah(12), Nathalie Parquet(11), Stéphane Giraudier(11), Kimberly Stegmaier(10), Emmanuelle Verger(10), Juliette Soret‐Dulphy(10), Clémence Marcault(9), Nicolas Gauthier(9), William Vainchenker(9), Gabriela Alexe(8), Hélène Pasquer(8), Blandine Roux(7), Frank Ling(7), Nina Fenouille(6), Lin‐Pierre Zhao(6)